Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non‐recurrent disease-Reference-Cited by-同舟云学术

Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non‐recurrent disease

Published:2019-03-08 Issue:4 Volume:17 Page:618-626
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Baker Stephen R.¹^ORCID,Zabczyk Michal²³,Macrae Fraser L.¹,Duval Cédric¹^ORCID,Undas Anetta²³,Ariëns Robert A. S.¹

Affiliation:

1. Leeds Thrombosis Collective Department of Discovery and Translational Science Leeds Institute of Cardiovascular and Metabolic Medicine University of Leeds Leeds UK

2. Institute of Cardiology Jagiellonian University Medical College Krakow Poland

3. John Paul II Hospital Krakow Poland

Funder

British Heart Foundation

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14402

Reference26 articles.

1. Update on Venous Thromboembolism

2. Venous thromboembolism: disease burden, outcomes and risk factors

3. Risk assessment for recurrent venous thrombosis

4. Predicting the risk of venous thromboembolism recurrence

5. Predictors of Recurrence After Deep Vein Thrombosis and Pulmonary Embolism

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies;Seminars in Thrombosis and Hemostasis;2024-06-18

2. Fibrinogen levels and clot properties identify patients who benefit from catheter-directed thrombolysis after DVT;Blood Advances;2024-06-03

3. Blood Clot Dynamics and Fibrinolysis Impairment in Cancer: The Role of Plasma Histones and DNA;Cancers;2024-02-25

4. Left atrium size and volume is associated with fibrin clot ultrastructure in patients with acute myocardial infarction;Polish Archives of Internal Medicine;2023-12-12

5. Fungi Fibrinolytic Compound 1 Plays a Core Role in Modulating Fibrinolysis, Altering Plasma Clot Structure, and Promoting Susceptibility to Lysis;Pharmaceutics;2023-09-14